Mineralys Therapeutics, Inc. (MLYS) Press Releases https://ir.mineralystx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/mineralystx/files/theme/images/logo-email.png Mineralys Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)]]> https://ir.mineralystx.com/news-events/press-releases/detail/108/mineralys-therapeutics-presents-late-breaking-data-on Sun, 14 Jun 26 10:00:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/108/mineralys-therapeutics-presents-late-breaking-data-on <![CDATA[Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference]]> https://ir.mineralystx.com/news-events/press-releases/detail/107/mineralys-therapeutics-to-participate-in-the-goldman-sachs Mon, 08 Jun 26 16:05:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/107/mineralys-therapeutics-to-participate-in-the-goldman-sachs <![CDATA[Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)]]> https://ir.mineralystx.com/news-events/press-releases/detail/106/mineralys-therapeutics-to-present-late-breaking-data-on Mon, 08 Jun 26 07:00:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/106/mineralys-therapeutics-to-present-late-breaking-data-on <![CDATA[Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock]]> https://ir.mineralystx.com/news-events/press-releases/detail/105/mineralys-therapeutics-announces-pricing-of-150-million Wed, 03 Jun 26 06:05:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/105/mineralys-therapeutics-announces-pricing-of-150-million <![CDATA[Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing]]> https://ir.mineralystx.com/news-events/press-releases/detail/104/mineralys-therapeutics-announces-repurchase-of-royalty Wed, 03 Jun 26 06:00:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/104/mineralys-therapeutics-announces-repurchase-of-royalty <![CDATA[Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)]]> https://ir.mineralystx.com/news-events/press-releases/detail/103/mineralys-therapeutics-presents-new-data-from-the-phase-3 Sat, 30 May 26 11:15:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/103/mineralys-therapeutics-presents-new-data-from-the-phase-3 <![CDATA[Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference]]> https://ir.mineralystx.com/news-events/press-releases/detail/102/mineralys-therapeutics-to-participate-in-the-jefferies Wed, 27 May 26 08:00:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/102/mineralys-therapeutics-to-participate-in-the-jefferies <![CDATA[Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)]]> https://ir.mineralystx.com/news-events/press-releases/detail/101/mineralys-therapeutics-announces-presentation-of-new-data Mon, 18 May 26 16:05:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/101/mineralys-therapeutics-announces-presentation-of-new-data <![CDATA[Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update]]> https://ir.mineralystx.com/news-events/press-releases/detail/100/mineralys-therapeutics-reports-first-quarter-2026-financial Wed, 06 May 26 16:05:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/100/mineralys-therapeutics-reports-first-quarter-2026-financial <![CDATA[Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)]]> https://ir.mineralystx.com/news-events/press-releases/detail/99/mineralys-therapeutics-reports-inducement-awards-under Tue, 05 May 26 17:34:00 -0400 https://ir.mineralystx.com/news-events/press-releases/detail/99/mineralys-therapeutics-reports-inducement-awards-under